SCN1A dysfunction and neuropsychiatric comorbidities
SCN1A 功能障碍和神经精神合并症
基本信息
- 批准号:8702781
- 负责人:
- 金额:$ 23.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAgeAge-MonthsAgreementAtaxiaBehavioralBehavioral ParadigmBrainClinicalClinical ManagementCognitiveComorbidityComplexDataDevelopmentDiseaseDrug ControlsEncephalopathiesEpilepsyEtiologyEventExhibitsExonsFamilyFebrile ConvulsionsFoundationsFrequenciesFunctional disorderGenerationsGenesGeneticHumanHyperactive behaviorHyperthermiaInborn Genetic DiseasesInduced HyperthermiaInfantIntellectual functioning disabilityInterventionKnock-in MouseKnock-outKnockout MiceKnowledgeLaboratoriesLeadLearningLifeLoxP-flanked alleleModelingMusMutant Strains MiceMutationNeuronsOutcomePatientsPlayQuality of lifeRecurrenceResearchResistanceRiskRoleSCN1A proteinSeizuresSeveritiesSiteSleep ArchitectureSocial InteractionSodium ChannelSyndromeTNFRSF5 geneTamoxifenTestingTimeTransgenic OrganismsTranslational ResearchValproic Acidbaseclinically relevantexperiencegenetic variantinnovationinsightloss of function mutationmouse modelmutantneuropsychiatrynovelpatient populationpostnatalpreventpublic health relevancerecombinaseresearch studytherapy developmenttraitvoltage
项目摘要
DESCRIPTION (provided by applicant): Mutations in the SCN1A voltage-gated sodium channel (VGSC) are responsible for a growing number of disorders, including Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+). DS is a catastrophic early-life encephalopathy associated with prolonged and recurrent early-life febrile seizures (FSs), treatment-resistant afebrile epilepsy, ataxia, and intellectual disability. GEFS+ is an inherited disorder characterized by FSs that persist beyond the age of six and the development of a wide range of adult epilepsy subtypes. To date, research has focused mainly on the seizure component of these disorders; however, we now recognize that seizure onset is often followed by cognitive stagnation/decline, hyperactivity, and the development of a number of behavioral comorbidities, including autistic and psychotic traits. Although seizure frequency does tend to decline during adulthood, these comorbidities persist and are a major challenge in the clinical management of this patient population. Currently, the cognitive and behavioral outcomes associated with SCN1A dysfunction are poorly characterized, and the factors that influence the severity of these deficits unknown. Mitigating the impact of these comorbidities on quality-of-life
outcomes will require broader research efforts to better characterize these cognitive and behavioral deficits, as well as identify factors that influence their severity. Towards this end, te proposed experiments in this R21 application will use Scn1a mouse models developed in our laboratory to address several fundamental gaps in our knowledge. Specifically, we will 1) better define the cognitive and behavioral deficits that result from altered SCN1A function, 2) determine whether prolonged early-life FSs, which are a common clinical feature of SCN1A-derived epilepsies, are likely to contribute to the worsening of cognitive and behavioral outcomes, and 3) determine whether the emergence of cognitive and behavioral abnormalities requires altered SCN1A function during the early period of postnatal brain development or is an invariant (age-independent) outcome of altered SCN1A function. These experiments are both innovative and clinically relevant, and will stimulate much-needed translational research.
描述(由申请人提供):SCN1A 电压门控钠通道 (VGSC) 突变导致越来越多的疾病,包括 Dravet 综合征 (DS) 和伴有热性惊厥的遗传性癫痫 (GEFS+)。 DS 是一种灾难性的早期脑病,与长期和反复出现的早期热性惊厥 (FS)、难治性非热性癫痫、共济失调和智力障碍有关。 GEFS+ 是一种遗传性疾病,其特征是 FS 持续到六岁以上,并发展为多种成人癫痫亚型。迄今为止,研究主要集中在这些疾病的癫痫发作方面。然而,我们现在认识到,癫痫发作后往往会出现认知停滞/下降、多动以及一系列行为合并症的发展,包括自闭症和精神病特征。尽管成年期癫痫发作频率确实会下降,但这些合并症仍然存在,并且是该患者群体临床管理的主要挑战。目前,与 SCN1A 功能障碍相关的认知和行为结果尚不清楚,影响这些缺陷严重程度的因素尚不清楚。减轻这些合并症对生活质量的影响
结果将需要更广泛的研究努力,以更好地描述这些认知和行为缺陷,并确定影响其严重程度的因素。为此,R21 应用中提出的实验将使用我们实验室开发的 Scn1a 小鼠模型来解决我们知识中的几个基本空白。具体来说,我们将1)更好地定义SCN1A功能改变导致的认知和行为缺陷,2)确定早期生命周期延长(SCN1A衍生性癫痫的常见临床特征)是否可能导致认知和行为结果恶化,以及3)确定认知和行为异常的出现是否需要在治疗期间改变SCN1A功能。 出生后大脑发育的早期阶段,或者是 SCN1A 功能改变的不变(与年龄无关)的结果。这些实验既具有创新性又具有临床相关性,并将刺激急需的转化研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew P Escayg其他文献
Andrew P Escayg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew P Escayg', 18)}}的其他基金
SCN8A encephalopathy: disease mechanisms and treatment
SCN8A 脑病:疾病机制和治疗
- 批准号:
10586642 - 财政年份:2023
- 资助金额:
$ 23.3万 - 项目类别:
Exploring the role of GADD45A in Alzheimer's disease
探索 GADD45A 在阿尔茨海默病中的作用
- 批准号:
10373344 - 财政年份:2022
- 资助金额:
$ 23.3万 - 项目类别:
Exploring the role of oxytocin in the regulation of neuronal excitability
探索催产素在神经元兴奋性调节中的作用
- 批准号:
10593062 - 财政年份:2021
- 资助金额:
$ 23.3万 - 项目类别:
Exploring the role of oxytocin in the regulation of neuronal excitability
探索催产素在神经元兴奋性调节中的作用
- 批准号:
10397642 - 财政年份:2021
- 资助金额:
$ 23.3万 - 项目类别:
Exploring the range of seizure and behavioral phenotypes due to SCN8A mutations
探索 SCN8A 突变引起的癫痫发作和行为表型的范围
- 批准号:
9978424 - 财政年份:2020
- 资助金额:
$ 23.3万 - 项目类别:
Exploring reversible AChE inhibitors as a treatment for refractory epilepsies
探索可逆的 AChE 抑制剂治疗难治性癫痫
- 批准号:
9764633 - 财政年份:2019
- 资助金额:
$ 23.3万 - 项目类别:
N-terminal huntingtin and Huntington disease neuropathology
N 末端亨廷顿蛋白和亨廷顿病神经病理学
- 批准号:
10117290 - 财政年份:2017
- 资助金额:
$ 23.3万 - 项目类别:
Towards the development of an effective treatment for SCN1A-derived epilepsy
致力于开发 SCN1A 源性癫痫的有效治疗方法
- 批准号:
9195849 - 财政年份:2016
- 资助金额:
$ 23.3万 - 项目类别:
Towards the development of an effective treatment for SCN1A-derived epilepsy
致力于开发 SCN1A 源性癫痫的有效治疗方法
- 批准号:
9272959 - 财政年份:2016
- 资助金额:
$ 23.3万 - 项目类别:
A novel target for the treatment of temporal lobe epilepsy
治疗颞叶癫痫的新靶点
- 批准号:
9087344 - 财政年份:2015
- 资助金额:
$ 23.3万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 23.3万 - 项目类别:
Research Grant














{{item.name}}会员




